is bydureon a glp 1 Holding GLP-1 Agonists Prior to Elective Procedures Bydureon vs Ozempic | Is

Notes: 1

doi: 10.1111/dom.14280 179 LarsenPJ

Although the purpose of the study was not to conduct quantitative analyses, questionnaire data showed a trend towards reduction in PHQ-9, GAD-7 and EDE-Q scores (Table 1), which were clinically significant given that change scores of 5, 4 and 0.57 are considered the minimal clinically important differences in PHQ-9, GAD-7 and total EDE-Q scores respectively [3840]

Monitoring body composition can provide insights: the scale may not change, but fat loss and muscle maintenance or gain might still be occurring

A synthetic version was created in the years after, but it took until 2005 for this GLP-1 agonist to become an FDA-approved treatment for type 2 diabetes